CERBA-HEALTHCARE
Cerba HealthCare, a leading global player in medical diagnosis, has been exploring new alternatives to transport biological samples that combine low carbon footprint, shorter time-to-results for patients and prescribers while allowing every patient to benefit from the analytical quality of large capacity laboratory platforms in a timely manner.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230307005636/en/
©Delivrone 2023
Over the past couple of weeks, France and Italy, two major affiliates of the Group, hosted drone-enabled sample transport and successfully performed their experimental flights in different conditions.
Jérôme Sallette, Chief Scientific Officer at Cerba HealthCare, comments: “Following the use cases we described in our white paper, the drone flight we experimented in Normandy with Cerballiance is a first step toward a broader and more sustainable approach of our logistic mix for sample transportation. It illustrates the long-standing drive for innovation within the Group and by 2024, we plan to identify how drones will prove an efficient complementary way of carrying biological samples”.
“Last week Cerba HealthCare Italia performed the first drone flight with biological samples embedded, involving some of the medical centers around the Metropolitan City of Milan, specifically in the two sites located in the cities of Opera and Rozzano” adds Stefano Massaro, Chief Executive Officer of Cerba HealthCare Italia. “We are dealing with the first air transport of blood samples not yet tested, experimented by the use of a drone. The result of this adventure today makes us confident and eager to pursue the path of innovation as a landmark of a leading quality service for patients”.
- To access the French flight video: https://youtu.be/rjy0e1kMluM
- To access the Italian flight video: https://www.youtube.com/watch?v=-wOCDJipasc
- To access the white paper: https://www.cerbahealthcare.com/en/drones-medical-logistics-opportunities-and-challenges
About Cerba HealthCare
Cerba HealthCare, a leading global player in medical diagnostics, aims to support the evolution of health systems towards more prevention. It draws on more than 50 years of expertise in clinical pathology to better assess the risk of diseases development, detect and diagnose diseases earlier, and optimize the effectiveness of personalized medicine.
Every day, on five continents, the Group's 15,000 employees sustain the transformation of medicine, driven by one deep conviction: to advance diagnosis is to advance health.
Cerba HealthCare, enlightening health.
Additional information is available at www.cerbahealthcare.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230307005636/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NTT DATA Recognized as a Global Top Employer for Third Consecutive Year15.1.2026 09:00:00 CET | Press release
NTT DATA, a global leader in AI, digital business and technology services, today announces it has been certified as a Global Top Employer for 2026 by the Top Employers Institute. Recognized for the third year in a row, this prestigious honor places NTT DATA among a select group of just 17 organizations worldwide honored for consistently delivering a high-performing people strategy across its global operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260115418660/en/ NTT DATA recognized as a Global Top Employer In addition to its global recognition, NTT DATA has also earned four Top Employer 2026 regional seals and 37 country and region seals across North America, Latin America, Asia Pacific, Europe and Africa. The Global Certification is the highest level of recognition offered by the Top Employers Institute and underscores NTT DATA’s ability to align its leadership, leverage data-driven insights and apply validated b
SAP and Syngenta Announce Partnership to Scale AI-Assisted Agriculture15.1.2026 09:00:00 CET | Press release
SAP SE (NYSE: SAP) and Syngenta, a global leader in agricultural innovation, today announced a multi-year strategic technology partnership to accelerate AI-assisted innovation across Syngenta’s global operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260115682130/en/ Jeff Rowe - CEO of Syngenta Group (left) and Christian Klein - CEO of SAP (right) The partnership will embed artificial intelligence at the core of Syngenta’s enterprise, modernizing operations and enabling accelerated innovation through advanced data analytics across the business — from manufacturing and supply chain to grower-facing products and services. Agriculture continues to navigate challenges driven by climate variability, supply chain complexity, and global uncertainty. By deploying AI-assisted tools enterprise-wide, this partnership positions Syngenta to meet the challenge of feeding a projected 10 billion people by 2050, while unlocking fast
Advanced Sterilization Products (ASP) Announces CE Mark for ULTRA GI™ Cycle for Duodenoscopes in Partnership with FUJIFILM Healthcare Europe15.1.2026 09:00:00 CET | Press release
New cycle for the STERRAD™ 100NX Sterilizer introduces a validated sterilization method for complex endoscopes, promoting patient safety through innovation. ASP International GmbH (“ASP”), a division of Fortive (NYSE: FTV), in collaboration with FUJIFILM Healthcare Europe GmbH, proudly announces that the ULTRA GI™ Cycle has received CE mark approval. The ULTRA GI™ Cycle is the latest innovation for the STERRAD™ 100NX Sterilizer with ALLClear™ Technology. The ULTRA GI™ Cycle’s receipt of the CE mark represents a pivotal advancement in elevating patient safety across healthcare facilities and addressing the complex challenges associated with traditional reprocessing methods. “This is a meaningful step forward in our mission to make duodenoscope reprocessing safer across Europe,” said Chad Rohrer, President, ASP. “By bringing hydrogen peroxide gas plasma sterilization into routine practice, we’re giving clinicians greater confidence to focus on what matters most – their patients.” ASP’s i
AWS Launches AWS European Sovereign Cloud and Announces Expansion Across Europe15.1.2026 08:00:00 CET | Press release
AWS announces the general availability of the AWS European Sovereign Cloud and plans to expand across Europe with new AWS Local Zones in Belgium, the Netherlands, and PortugalAmazon plans to invest more than €7.8 billion in the AWS European Sovereign Cloud in Germany and support an average of 2,800 full-time equivalent jobs annually Today, Amazon Web Services (AWS) announced the general availability of the AWS European Sovereign Cloud, a new, independent cloud for Europe entirely located within the EU, and physically and logically separate from other AWS Regions. The AWS European Sovereign Cloud’s unique approach provides the only fully featured, independently operated sovereign cloud backed by strong technical controls, sovereign assurances, and legal protections designed to meet the needs of European governments and enterprises for sensitive data. AWS also announced plans to extend the AWS European Sovereign Cloud footprint from Germany across the EU to support stringent isolation, i
Cargill Advances Maritime Decarbonisation with Delivery of First Green Methanol Dual-Fuel Vessel15.1.2026 08:00:00 CET | Press release
Brave Pioneer is the first in a new fleet of chartered vessels designed to scale Cargill’s investment to low-carbon innovation across dry-bulk shipping Cargill today announced the maiden voyage of Brave Pioneer, the first of five green methanol dual-fuel dry bulk vessels chartered by the company. The deployment of the Brave Pioneer marks another important milestone in Cargill’s broader decarbonization efforts – one focused on innovation, testing and learning as the company works with customers and partners to refine future-ready solutions for Cargill and the industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260114083757/en/ Built by Tsuneishi Shipbuilding Co., Ltd. and owned by Mitsui & Co. Ltd., Brave Pioneer is equipped to operate on both conventional marine fuels and green methanol, a lower-carbon alternative. Built by Tsuneishi Shipbuilding Co., Ltd. and owned by Mitsui & Co. Ltd., Brave Pioneer is equipped to ope
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom